BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36809933)

  • 1. Targeting Ion Channels for the Treatment of Glioma.
    Keluth S; Jitte S; Bhushan R; Ranjan OP; Murti K; Ravichandiran V; Kumar N
    Mini Rev Med Chem; 2023; 23(12):1298-1318. PubMed ID: 36809933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Channels in Gliomas-From Molecular Basis to Treatment.
    Elias AF; Lin BC; Piggott BJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channels and Their Role in the Pathophysiology of Gliomas.
    Takayasu T; Kurisu K; Esquenazi Y; Ballester LY
    Mol Cancer Ther; 2020 Oct; 19(10):1959-1969. PubMed ID: 33008831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of TRPM channels in glioma.
    Chen Z; Xie H; Liu J; Zhao J; Huang R; Xiang Y; Wu H; Tian D; Bian E; Xiong Z
    Cancer Biol Ther; 2024 Dec; 25(1):2338955. PubMed ID: 38680092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
    D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
    Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
    Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
    Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives.
    Lefranc F
    Front Cell Dev Biol; 2021; 9():618961. PubMed ID: 34458247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential biochemical therapy of glioma cancer.
    Yin LT; Fu YJ; Xu QL; Yang J; Liu ZL; Liang AH; Fan XJ; Xu CG
    Biochem Biophys Res Commun; 2007 Oct; 362(2):225-9. PubMed ID: 17707767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications.
    Younes S; Mourad N; Salla M; Rahal M; Hammoudi Halat D
    Membranes (Basel); 2023 Apr; 13(4):. PubMed ID: 37103862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Ion Channel Targets and Drug Delivery Tools for Controlling Glioblastoma Cell Invasiveness.
    Varricchio A; Ramesh SA; Yool AJ
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communication of Glioma cells with neuronal plasticity: What is the underlying mechanism?
    Melgarejo da Rosa M
    Neurochem Int; 2020 Dec; 141():104879. PubMed ID: 33068685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ion channels in malignant brain tumors.
    Simon OJ; Müntefering T; Grauer OM; Meuth SG
    J Neurooncol; 2015 Nov; 125(2):225-35. PubMed ID: 26334315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-Depolarizing Channel Blockers Induce Selective Glioma Cell Death by Impairing Nutrient Transport and Unfolded Protein/Amino Acid Responses.
    Niklasson M; Maddalo G; Sramkova Z; Mutlu E; Wee S; Sekyrova P; Schmidt L; Fritz N; Dehnisch I; Kyriatzis G; Krafcikova M; Carson BB; Feenstra JM; Marinescu VD; Segerman A; Haraldsson M; Gustavsson AL; Hammarström LG; Jenmalm Jensen A; Uhrbom L; Altelaar AF; Linnarsson S; Uhlén P; Trantirek L; Vincent CT; Nelander S; Enger PØ; Andäng M
    Cancer Res; 2017 Apr; 77(7):1741-1752. PubMed ID: 28087597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion channels and amino acid transporters support the growth and invasion of primary brain tumors.
    Sontheimer H
    Mol Neurobiol; 2004 Feb; 29(1):61-71. PubMed ID: 15034223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro.
    Wang WX; Ji YH
    J Neurooncol; 2005 May; 73(1):1-7. PubMed ID: 15933810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
    Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
    J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas.
    Bomben VC; Turner KL; Barclay TT; Sontheimer H
    J Cell Physiol; 2011 Jul; 226(7):1879-88. PubMed ID: 21506118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas.
    Bomben VC; Sontheimer HW
    Cell Prolif; 2008 Feb; 41(1):98-121. PubMed ID: 18211288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.